Description
Gusacitinib is a dual inhibitor of SYK/JAK kinases.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Gusacitinib is a dual inhibitor of SYK/JAK kinases.
| Cas No. | 1425381-60-7 |
|---|---|
| Purity | ≥98% |
| Formula | C24H28N8O2 |
| Formula Wt. | 460.54 |
| IUPAC Name | 2-[1-[4-[4-(4-hydroxypiperidin-1-yl)anilino]-5-oxo-6H-pyrimido[4,5-d]pyridazin-2-yl]piperidin-4-yl]acetonitrile |
| Synonym | ASN-002, ASN002 |
| Appearance | Yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Montilla A, Gomez-Garcia F, Gomez-Arias P, et al. Scoping review on the use of drugs targeting JAK/STAT pathway in atopic dermatitis, vitiligo, and alopecia areata. Dermatol The (Heidelb). 2019 Dec;9(4):655-683. PMID: 31606872
May be useful against COVID-19
SIRT2 inhibitor.
Synthetic steroid; glucocorticoid agonist.
Endogenous cardiomodulatory peptide; NPR-A agon...
Endogenous peptide hormone fragment, involved i...
Endogenous peptide, cleavage product of angiote...
Naturally produced ITC, sulfonyl analog of sulf...
Macrolide; protein synthesis inhibitor. ≥3900...
Naturally sourced ITC, sulfonyl analog of sulfo...
Endogenous peptide, involved in vascular contra...
Endogenous quaternary ammonium, required for fa...
mTOR activator.
Amino acid alcohol.
ATP-sensitive K+ channel activator, α-adrenerg...
Cyclosporin metabolite; weak calmodulin inhibit...
ACE inhibitor.
BH3 mimetic; Bcl-2 inhibitor.
α3β2, α3β4, α4β2 nAChR antagonist, indire...
GABA-A agonist, NMDA antagonist, voltage-gated ...
Lincosamide; ribosomal translocation and protei...